BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34772794)

  • 21. Comparative dosimetry between
    Jadoul A; Bernard C; Lovinfosse P; Gérard L; Lilet H; Cornet O; Hustinx R
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):828-837. PubMed ID: 31388721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat Evaluation of Lung Shunt Fraction is Unnecessary: A Retrospective Observational Study of Successive Lung Shunt Fractions from Variable Arterial Distributions in Patients Undergoing Radioembolization of Primary and Secondary Liver Tumors.
    Bulman JC; Zurkiya O; Wu V; Wehrenberg-Klee E; Palmer E; Chow D; Brook A; Ganguli S
    J Vasc Interv Radiol; 2021 Mar; 32(3):412-418. PubMed ID: 33341340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG
    J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of perfused volume segmentation between cone-beam CT and
    Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
    Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An In-House 3D Voxel Dosimetric Tool to Compare Predictive and Post- Treatment Dosimetry in
    Ferrando O; Bampi R; Foppiano F; Ciarmiello A
    Curr Radiopharm; 2023 Jun; 16(3):214-221. PubMed ID: 36790008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Planning dosimetry for
    Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC
    Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
    Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioembolization of hepatocarcinoma with
    Chiesa C; Mira M; Bhoori S; Bormolini G; Maccauro M; Spreafico C; Cascella T; Cavallo A; De Nile MC; Mazzaglia S; Capozza A; Tagliabue G; Brusa A; Marchianò A; Seregni E; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3018-3032. PubMed ID: 32451604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization.
    Kao YH; Magsombol BM; Toh Y; Tay KH; Chow PKh; Goh AS; Ng DC
    EJNMMI Res; 2014; 4():33. PubMed ID: 25024931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E; Rolland Y; Edeline J; Icard N; Lenoir L; Laffont S; Mesbah H; Breton M; Sulpice L; Boudjema K; Rohou T; Raoul JL; Clement B; Boucher E
    J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.
    Ulrich G; Dudeck O; Furth C; Ruf J; Grosser OS; Adolf D; Stiebler M; Ricke J; Amthauer H
    J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres.
    d'Abadie P; Walrand S; Goffette P; Amini N; Maanen AV; Lhommel R; Jamar F
    Diagn Interv Radiol; 2021 Nov; 27(6):768-773. PubMed ID: 34792032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET-CT post therapy dosimetry in radioembolization with resin
    Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M
    Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of
    Allred JD; Niedbala J; Mikell JK; Owen D; Frey KA; Dewaraja YK
    EJNMMI Res; 2018 Jun; 8(1):50. PubMed ID: 29904808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT.
    Haste P; Tann M; Persohn S; LaRoche T; Aaron V; Mauxion T; Chauhan N; Dreher MR; Johnson MS
    J Vasc Interv Radiol; 2017 May; 28(5):722-730.e1. PubMed ID: 28238581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The superior predictive value of
    Smits MLJ; Dassen MG; Prince JF; Braat AJAT; Beijst C; Bruijnen RCG; de Jong HWAM; Lam MGEH
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):798-806. PubMed ID: 31399801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioembolization lung shunt estimation based on a
    Kunnen B; van der Velden S; Bastiaannet R; Lam MGEH; Viergever MA; de Jong HWAM
    Med Phys; 2018 Oct; 45(10):4744-4753. PubMed ID: 30179259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
    J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
    Haug AR; Heinemann V; Bruns CJ; Hoffmann R; Jakobs T; Bartenstein P; Hacker M
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1037-45. PubMed ID: 21308371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.